Potential applications & Growth of Antiemetic Market in Pharmaceutical Industry
Feb 20, 2018 06:06 am UTC| Business
NEW YORK, Feb. 20, 2018 -- Antiemetic also known as anti-vertigo is a drug class effective against vomiting and nausea. Vomiting is controlled by the vomiting centre in the medulla of brain. It is controlled by...
SoftServe and Adjoint Deliver the Future of Blockchain in FinTech
Feb 20, 2018 06:00 am UTC| Business
LONDON, Feb. 20, 2018 -- SoftServe, a leading digital consulting company, today announced its partnership with Adjoint, a developer of distributed ledger technology to accelerate automation through smart contracts and...
Magnificent Future of “Global Competent Cells” Market: Find Out Its Benefits- Profshare Market Share
Feb 20, 2018 05:52 am UTC| Business
NEW YORK, Feb. 20, 2018 -- Global Competent Cells Market by Type (Chemically Competent Cells, Electro competent Cells) by Application/End User (Subcloning Routine Cloning, Phage Display Library...
Global Intraocular Lens Market Will Reach USD 4,500 million by 2022: Zion Market Research
Feb 20, 2018 05:51 am UTC| Business
New York, NY, Feb. 20, 2018 -- Zion Market Research has published a new report titled “Intraocular Lens Market by Type (Monofocal IOLs and Premium IOLs); By Application (Cataract Surgery, Refractive Lens Exchange...
CLINUVEL unveils new global positioning
Feb 20, 2018 03:47 am UTC| Business
MELBOURNE, Australia, Feb. 19, 2018 -- CLINUVEL PHARMACEUTICALS LTD (ASX:CUV) (XETRA-DAX:UR9) (NASDAQ INTERNATIONAL DESIGNATION ADR:CLVLY) today released its new global Company positioning including the unveiling of a...
Focusing on applications, INTchain is the real valuable blockchain
Feb 20, 2018 02:53 am UTC| Business
BEIJING, Feb. 20, 2018 -- Once again, Bitcoin ignited the Spring Festival social circle, becoming a hot topic on the table. World's public opinion take "blockchain" this vocabulary quickly heated and spread to the...
Adamas Announces Declaratory Judgment Action Filed by Osmotica Related to Approved OSMOLEX ER
Feb 20, 2018 01:01 am UTC| Business
EMERYVILLE, Calif., Feb. 19, 2018 -- Adamas Pharmaceuticals, Inc. (NASDAQ:ADMS) announced today that it has learned that Osmotica Pharmaceuticals LLC and Vertical Pharmaceuticals LCC (Osmotica) filed an action in...